Previous close | 85.17 |
Open | 84.88 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 84.88 - 85.90 |
52-week range | 68.84 - 91.00 |
Volume | |
Avg. volume | 5,963,127 |
Market cap | 113.874B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 27.23 |
EPS (TTM) | 3.15 |
Earnings date | 23 May 2024 |
Forward dividend & yield | 2.76 (3.22%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | 94.00 |
Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
Most readers would already be aware that Medtronic's (NYSE:MDT) stock increased significantly by 5.7% over the past...
On Friday, Medtronic plc (NYSE:MDT) released results from the SPHERE Per-AF study comparing Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 System. The findings were presented as late-breaking clinical data at the Heart Rhythm Society 2024 Annual Meeting and published in Nature Medicine. The study demonstrated the safety and efficacy of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one pulsed field (PF) and radiof